CATENA, Cristiana
 Distribuzione geografica
Continente #
NA - Nord America 22.114
AS - Asia 9.205
EU - Europa 7.065
SA - Sud America 1.796
Continente sconosciuto - Info sul continente non disponibili 922
AF - Africa 212
OC - Oceania 13
Totale 41.327
Nazione #
US - Stati Uniti d'America 21.770
SG - Singapore 4.357
CN - Cina 1.884
UA - Ucraina 1.850
BR - Brasile 1.389
IT - Italia 1.339
DE - Germania 1.110
HK - Hong Kong 976
FI - Finlandia 801
VN - Vietnam 602
RU - Federazione Russa 484
FR - Francia 386
IE - Irlanda 314
IN - India 246
TR - Turchia 237
SE - Svezia 215
BD - Bangladesh 200
GB - Regno Unito 191
CA - Canada 186
AR - Argentina 159
KR - Corea 138
IQ - Iraq 83
MX - Messico 78
JP - Giappone 68
CO - Colombia 65
PK - Pakistan 64
NL - Olanda 63
ZA - Sudafrica 59
ID - Indonesia 58
EC - Ecuador 57
BE - Belgio 54
AT - Austria 48
ES - Italia 45
PL - Polonia 44
SA - Arabia Saudita 39
VE - Venezuela 39
UZ - Uzbekistan 36
MA - Marocco 30
CZ - Repubblica Ceca 27
CL - Cile 24
JO - Giordania 22
MY - Malesia 22
EU - Europa 21
EG - Egitto 20
PY - Paraguay 19
PE - Perù 18
IR - Iran 17
JM - Giamaica 16
KE - Kenya 16
LB - Libano 16
TN - Tunisia 16
CR - Costa Rica 15
PH - Filippine 15
AE - Emirati Arabi Uniti 14
UY - Uruguay 14
NP - Nepal 13
AU - Australia 12
DZ - Algeria 11
IL - Israele 11
OM - Oman 11
RS - Serbia 11
AZ - Azerbaigian 10
ET - Etiopia 10
KZ - Kazakistan 10
BO - Bolivia 9
TG - Togo 9
AL - Albania 8
CH - Svizzera 8
TT - Trinidad e Tobago 8
XK - ???statistics.table.value.countryCode.XK??? 8
LT - Lituania 7
SK - Slovacchia (Repubblica Slovacca) 7
TW - Taiwan 7
DO - Repubblica Dominicana 6
EE - Estonia 6
KH - Cambogia 6
PA - Panama 6
PS - Palestinian Territory 6
PT - Portogallo 6
RO - Romania 6
SN - Senegal 6
SV - El Salvador 6
AM - Armenia 5
GT - Guatemala 5
TH - Thailandia 5
BW - Botswana 4
DK - Danimarca 4
GR - Grecia 4
HU - Ungheria 4
KG - Kirghizistan 4
RE - Reunion 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
CY - Cipro 3
GY - Guiana 3
HN - Honduras 3
HR - Croazia 3
MU - Mauritius 3
NO - Norvegia 3
QA - Qatar 3
Totale 40.366
Città #
Woodbridge 2.091
Singapore 1.881
Fairfield 1.831
Ashburn 1.657
Ann Arbor 1.475
Jacksonville 1.308
Houston 1.133
San Jose 1.101
Chandler 975
Hong Kong 970
Beijing 875
Dearborn 788
Wilmington 784
Seattle 728
Cambridge 649
Council Bluffs 644
Boardman 455
Princeton 338
Dublin 311
Lauterbourg 309
Munich 270
Los Angeles 255
Helsinki 205
Buffalo 190
Udine 183
Dallas 166
Izmir 163
Santa Clara 154
Ho Chi Minh City 153
Hefei 150
Milan 141
New York 138
San Diego 129
Hanoi 127
Seoul 124
São Paulo 109
Redondo Beach 96
The Dalles 88
Ottawa 79
Des Moines 78
Pittsburgh 77
Ogden 71
Orem 68
Norwalk 65
Rome 60
Tokyo 59
Dong Ket 53
Frankfurt am Main 53
Nanjing 51
Mumbai 50
Kunming 49
Redmond 47
Atlanta 46
Rio de Janeiro 45
San Mateo 45
Brooklyn 44
Warsaw 43
Guangzhou 42
Brussels 40
Phoenix 40
Chicago 39
Nuremberg 39
Denver 36
Baghdad 34
Belo Horizonte 34
Johannesburg 33
London 33
Manchester 33
Chennai 31
Stockholm 31
Tashkent 31
Amsterdam 30
Brasília 30
Montreal 30
Boston 29
Shanghai 29
San Francisco 28
Vienna 26
Grafing 25
Trieste 25
Da Nang 24
Falls Church 24
Haiphong 24
Dhaka 23
Mexico City 23
Brno 22
Toronto 22
Turku 22
Ankara 21
Washington 21
Düsseldorf 20
Jinan 20
Miano 20
New Delhi 20
Bogotá 19
Porto Alegre 19
Quito 19
Amman 18
Goiânia 18
Lahore 18
Totale 25.392
Nome #
Alcohol-induced endothelial changes are associated with oxidative stress and are rapidly reversed after withdrawal 384
Alcohol Intake and Arterial Hypertension: Retelling of a Multifaceted Story 279
Decreased fibrinolytic activity is associated with carotid artery stiffening in arterial hypertension 273
Abnormalities of glucose metabolism and cardiovascular events in patients with hypertensive nephrosclerosis and mild renal failure 251
Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies 247
Abnormalities of insulin receptors in spontaneously hypertensive rats 216
Aldosterone and the heart: from basic research to clinical evidence 212
Aldosterone and Left Ventricular Remodeling 204
Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance 203
Early renal failure as a cardiovascular disease: Focus on lipoprotein(a) and prothrombotic state 194
Aldosterone and the heart: still an unresolved issue? 186
Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: relevance for cardiovascular outcomes 186
Omega-3 Fatty Acids: from Biochemistry to their Clinical Use in the Prevention of Cardiovascular Disease 186
Abnormalities of glucose metabolism in patients with early renal failure 184
Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism 183
Mineralocorticoid Receptor Blockers and Aldosterone to Renin Ratio: A Randomized Controlled Trial and Observational Data 183
Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension 182
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 178
Long-Term Renal and Cardiac Outcomes after Stenting in Patients with Resistant Hypertension and Atherosclerotic Renal Artery Stenosis 178
Aldosterone, Organ Damage, and Dietary Salt 178
Role of Aldosterone in Insulin Resistance: Fact of Fantasy 177
Vasculite dei vasa-nervorum: risposta alla terapia immunosoppressiva. Case Report 175
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 174
Relationships of plasma renin levels with renal function in patients with primary aldosteronism 171
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. 170
Benzodiazepines regulate the vascular tone vie an endothelium-independent mechanism 169
Abnormalities of coagulation in hypertensive patients with early renal failure: association with cardiovascular events 167
Moderate alcohol consumption is associated with left ventricular diastolic dysfunction in nonalcoholic hypertensive patients 167
Diabetes, diabetic complications, and blood pressure targets 166
Fish Meal Supplementation and Ambulatory Blood Pressure in Patients With Hypertension: Relevance of Baseline Membrane Fatty Acid Composition 166
Editorial comment from Dr Catena, Dr Colussi, and Dr Sechi to preoperative masse renal damage in japanese patients with primry aldosteronism: identification of predictors for chronic kidney disease manifested after adrenalectomy. 165
Glucose metabolism and insulin receptor binding and mRNA levels in tissues of Dahl hypertensive rats 165
Elevated homocysteine levels are associated with the metabolic syndrome and cardiovascular events in hypertensive patients 165
Relationship of Plasma Renin With a Prothrombotic State in Hypertension: Relevance for Organ Damage 164
Effects of angiotensin II (ANG II) infusion on insulin receptor binding and gene expression in the kidney of normal and diabetic rats 164
Pre-Procedural Statin Use Is Associated with Improved Long-Term Survival and Reduced Major Cardiovascular Events in Patients Undergoing Carotid Artery Stenting: A Retrospective Study 164
Predictors of target-organ damage in hypertension: role of lipoprotein(a) [Lp(a)] and apo(a) isoforms 163
A Prothrombotic State is Associated with Early Arterial Damage in Hypertensive Patients 162
Treatment of primary aldosteronism and organ protection 161
Insulin Resistance and High Blood Pressure: Mechanistic Insight on the Role of the Kidney 161
Prohypertensive effect of insulin: possible role of the sympathetic system 160
Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage? 160
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 160
The emergent cardiovascular risk factors and organ damage in arterial hypertension 159
Salt, hypertension, and cardiovascular disease 157
Intrarenal Vascular Resistance is Associated with a Prothrombotic State in Hypertensive Patients 157
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 157
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 156
Cardiovascular outcomes in patients with primary aldosteronism after treatment 156
The Metabolic Syndrome and the Membrane Content of Polyunsaturated Fatty Acids in Hypertensive Patients 155
The SPARTACUS Trial: Controversies and Unresolved Issues 154
Spontaneous restoration of sinus rhythm after cardiac surgery 154
Involvement of endothelium-dependent and -independent mechanisms in midazolam-induced vasodilation 154
Aldosterone plasmatico e escrezione urinaria di albumina nell’ipertensione arteriosa 152
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension 152
Elevated Blood Pressure in Children of Cardiovascular Risk Mothers: Could Maternal Folic Acid Be the Link? 152
Renal hyperfiltration and increased prevalence of cystic disease in patients with primary aldosteronism 151
A prothrombotic state is associated with increased carotid intima-media thickness in hypertension 151
Renal antioxidant enzyme mRNA levels are increased in rats with experimental diabetes mellitus 151
Autonomic dysfunction in hyperadrenergic orthostatic hypotension 151
Prevalence and determinants of resistant hypertension in a sample of patients followed in Italian hypertension centers: Results from the MINISAL-SIIA study program 149
Association of non-alcoholic fatty liver disease with left ventricular changes in treatment-naive patients with uncomplicated hypertension 148
Insulin receptors and renal sodium handling in hypertensive fructose-fed rats 147
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients 147
Mineralocorticoid Receptor Antagonists and Clinical Outcomes in Primary Aldosteronism: As Good as Surgery? 147
Benzodiazepines: an old class of new antihypertensive drugs? 147
The dual role of the kidney in primary aldosteronism: key determinant in rescue from volume expansion and persistence of hypertension 146
Renal function in primary aldosteronism 145
The vascular response to vasodilators is related to the membrane content of polyunsaturated fatty acids in hypertensive patients 145
Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension 144
Kidney in primary aldosteronism: a key determinant of treatment outcome 144
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trial 144
Glucose metabolism in early renal failure 143
Potassium-sparing diuretics in hypertension 142
Evaluation of endothelial function in patients with non-alcoholic fatty liver disease 141
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort 141
Association of Post-Saline Load Plasma Aldosterone Levels with Left Ventricular Hypertrophy in Primary Hypertension 141
Abnormalities of carbohydrate metabolism and cardiovascular disease in patients with early renal failure 140
Benign familial macrocytosis 140
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 140
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension Study 139
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: The EPATH trial 138
Effects of zofenopril, carvedilol, and lacidipine on alcohol-induced responses in cultured human endothelial cells 137
Association of aldosterone with left ventricular mass in hypertension: interaction with plasma fibrinogen levels 137
Serum lipoprotein(a) concentrations and alcohol consumption in hypertension: possible relevance for cardiovascular damage 137
Effects of the consumption of fish meals on the carotid IntimaMedia thickness in patients with hypertension: a prospective study 137
New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a) 137
Carotid artery stiffness is related to hyperinsulinemia and insulin-resistance in middle-aged, non-diabetic hypertensive patients 137
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 137
Spironolactone, eplerenone and the new aldosterone blockers in endocrine and primary hypertension 136
Impact of statin therapy on plasma levels of plasminogen activator inhibitor-1: A systematic review and meta-analysis of randomised controlled trials 136
Atrial fibrillation and its complications in arterial hypertension: The potential preventive role of ω-3 polyunsaturated fatty acids 136
AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY 135
Studio del ruolo del sistema simpatico nell’effetto proipertensivo dell’insulina. 135
Endothelial function in patients with non-alcoholic fatty liver disease 135
ACIDI GRASSI POLIINSATURI OMEGA-3 E FATTORI DI RISCHIO CARDIOVASCOLARE 135
Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study 134
Osteoprotegerin increases in metabolic syndrome and promotes adipose tissue proinflammatory changes 134
Increased fibrinogen levels and hemostatic abnormalities in patients with arteriolar nephrosclerosis: association with cardiovascular events 134
Hypertension and abnormalities of carbohydrate metabolism: possible role of sympathetic nervous system 133
Totale 16.322
Categoria #
all - tutte 160.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 160.674


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.082 0 0 98 182 69 88 145 160 26 414 474 426
2022/20232.604 371 118 36 299 234 781 11 166 377 49 88 74
2023/2024870 141 72 55 42 167 93 26 21 105 34 9 105
2024/20255.930 141 420 174 184 116 320 396 383 640 431 1.073 1.652
2025/202611.394 783 1.138 906 1.015 1.668 901 1.490 377 907 1.043 731 435
2026/20271.653 291 969 393 0 0 0 0 0 0 0 0 0
Totale 41.327